Vaxtex Cotfab Limited

VCL.NS

Manufacturing - Textiles · Consumer Cyclical

Price

₹1.61

+0.07 (+4.55%)

Market Cap

₹295.8M

Exchange

National Stock Exchange of India

Winston Score

Winston is serious

Mixed quality — meaningful strengths and weaknesses.

Data as of Aug 13, 2026 · filings through Mar 31, 2026

How the score breaks down

Quality

Weak

Growth

Strong

Cash Flow

Weak

Stability

Exceptional

Valuation

Good

Track this stock — start free trial

Share count rising — dilution

+74.4% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 105.6M (2022) → 184.2M (2026)

Winston Score History

The full picture

Vaxtex Cotfab Limited is an Indian textile manufacturer that makes cotton and blended fabrics. The company produces woven fabrics used in clothing and apparel, selling primarily to garment makers, wholesalers, and retailers across India. It operates in the broader Indian textile industry, which is one of the largest in the world.

The company earns money by selling fabric in bulk to business customers, making it a business-to-business manufacturer rather than a consumer brand. Vaxtex Cotfab is a relatively small company with a market cap around $0.3 billion, operating mainly within India. Its operating margin of roughly 17% is decent for a fabric maker, suggesting some cost discipline, but the company faces real risks from raw cotton price swings, competition from larger textile mills, and pressure from cheaper imports. The key growth opportunity lies in India's expanding domestic apparel market and any potential to supply export markets, though currency and global demand shifts could create headwinds.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-100.0% YoY

YoY Growth Rate

Revenue declining

EPS Growth

-43.3% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$0/ year

0.0% of revenue

Below sector average (4%)

Research and development spending

Insider Activity

17.4%ownership

Insiders own a meaningful stake in the company

Cash Position

Cash flow positive

$18M cash & investments

Company generates more cash than it spends — no dilution risk from fundraising

Revenue declining

Vaxtex Cotfab Limited's revenue is actually shrinking. In a growth stock, that removes the core investment thesis. The low Winston Score here may be warranted — unless there's a turnaround story.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

N/A

Data not available

Operating Margin

N/A

Data not available

ROCE

-0.3%

Weak — -0.3% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

+111.6%

Fast-growing sales (+111.6% YoY)

EPS YoY

+516.2%

Earnings growing fast (+516.2% YoY)

Earnings growing 25%+ a year. The compounder zone.

EPS Consistency

5/8 quarters

Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

-16%

Weak — only -16% of profit becomes cash

FCF Margin

-7.8%

Burning cash (-7.8%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

0.23

Conservative — low debt load (0.23)

Interest Cover

25.66x

Comfortably covers interest (25.7x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

5.5x

Attractive valuation — P/E 5.5

P/E under 10. The price tag is small relative to last year's profit.

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial